Illumina, Inc. (BIT:1ILMN)

Italy flag Italy · Delayed Price · Currency is EUR
84.73
0.00 (0.00%)
At close: Jul 18, 2025, 5:30 PM CET
Market Cap13.76B
Revenue (ttm)4.00B
Net Income (ttm)-891.81M
Shares Outn/a
EPS (ttm)-5.61
PE Ration/a
Forward PE23.64
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume14
Open84.73
Previous Close84.73
Day's Range84.73 - 84.73
52-Week Range61.21 - 142.10
Betan/a
RSI48.35
Earnings DateAug 7, 2025

About Illumina

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole... [Read more]

Industry Laboratory Analytical Instruments
Founded 1998
Employees 9,030
Stock Exchange Borsa Italiana
Ticker Symbol 1ILMN
Full Company Profile

Financial Performance

In 2024, Illumina's revenue was $4.37 billion, a decrease of -2.93% compared to the previous year's $4.50 billion. Losses were -$1.22 billion, 5.34% more than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.